Posts Tagged ‘pediatric cancer’

Voices of Childhood Cancer came alive March 1 – 3 on the 10th floor of OHSU Doernbecher Children’s Hospital. That’s when StoryCorps staff audio recorded the 40-minute conversations of 18 “interview pairs” for our Doernbecher-StoryCorps oral history project. StoryCorps’ mission is to celebrate and honor one another’s lives through listening; they have recorded close to 100,000 interview pairs throughout the United States, all archived in the Folklife section of the National Library of Congress. The Doernbecher … Read More

On a recent morning, I dealt with the death of one of my patients.  As sometimes happens with this job, instead of having time to process this, I was immediately faced with a busy clinic. After all of the patients were seen, and I had time to reflect, I realized that on the same day that cancer took the life of one of my patients, I had referred three other patients to our survivorship clinic. … Read More

The principal aim of the Doernbecher Children’s Hospital Development Therapeutics program is to evaluate novel agents for the treatment of pediatric cancer through early phase clinical trials. We conduct Phase I and Phase II trials of potentially promising new drugs for the treatment of all types of childhood cancer. Doernbecher is one of 21 select institutions in North America who comprise the NCI-funded Children’s Oncology Group Phase I Consortium. Through our participation in COG early … Read More